Omar Al-Massadi Selected Research

2- methyl- N- ((2'- (pyrrolidin- 1- ylsulfonyl)biphenyl- 4- yl)methyl)propan- 1- amine

3/2022

Kappa-Opioid Receptor Blockade Ameliorates Obesity Caused by Estrogen Withdrawal via Promotion of Energy Expenditure through mTOR Pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omar Al-Massadi Research Topics

Disease

15	Obesity 03/2024 - 08/2007
9	Body Weight (Weight, Body) 01/2021 - 08/2004
3	Weight Gain 03/2022 - 02/2016
3	AIDS-Related Complex (ARC) 01/2021 - 12/2015
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 11/2013
2	Insulin Resistance 11/2022 - 10/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2020 - 08/2019
2	Inflammation (Inflammations) 01/2020 - 10/2016
2	Hyperphagia (Overeating) 12/2019 - 12/2015
2	Glucose Intolerance 12/2019 - 11/2013
2	Weight Loss (Weight Reduction) 12/2019 - 08/2019
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 06/2012
2	Anorexia 12/2015 - 10/2010
1	Starvation 11/2022
1	Body Weight Changes 03/2022
1	Hypertrophy 11/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Constipation 01/2020
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Fibrosis (Cirrhosis) 10/2016
1	Fatty Liver 10/2016
1	Cachexia 12/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2013
1	Hyperglycemia 11/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2013
1	Non-alcoholic Fatty Liver Disease 03/2013
1	Neoplasms (Cancer) 12/2009

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 01/2020 - 08/2004
6	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 11/2013
6	GhrelinIBA 01/2020 - 08/2007
4	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2021 - 01/2018
3	LeptinIBA 03/2024 - 10/2010
3	fibroblast growth factor 21IBA 11/2022 - 11/2013
2	kappa Opioid Receptors (kappa Opioid Receptor)IBA 03/2022 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2015
2	LigandsIBA 01/2020 - 08/2004
2	Sirtuin 1IBA 12/2019 - 11/2014
2	Glucagon (Glukagon)FDA Link 08/2019 - 12/2015
2	Glucagon Receptors (Glucagon Receptor)IBA 08/2019 - 12/2015
2	melanin-concentrating hormone receptorIBA 10/2016 - 03/2013
1	2- methyl- N- ((2'- (pyrrolidin- 1- ylsulfonyl)biphenyl- 4- yl)methyl)propan- 1- amineIBA 03/2022
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2022
1	Estrogens (Estrogen)FDA Link 03/2022
1	Sirtuin 3IBA 01/2021
1	Insulin (Novolin)FDA Link 11/2020
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2020
1	linaclotideIBA 01/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2019
1	Hormones (Hormone)IBA 08/2019
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2018
1	JNK Mitogen-Activated Protein KinasesIBA 01/2018
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 10/2016
1	Narcotic Antagonists (Opioid Antagonists)IBA 10/2016
1	Methionine (L-Methionine)FDA Link 10/2016
1	Choline (Choline Chloride)IBA 10/2016
1	uroguanylinIBA 02/2016
1	AntibodiesIBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 11/2013
1	HDL LipoproteinsIBA 11/2013
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2013
1	CytokinesIBA 06/2012
1	InterleukinsIBA 06/2012
1	Ghrelin ReceptorsIBA 10/2010
1	NeuropeptidesIBA 08/2004

Therapy/Procedure

4	Therapeutics 11/2022 - 11/2013
1	Ovariectomy (Oophorectomy) 03/2022
1	Polypharmacy 01/2019